Evidence is emerging for the power of fecal immunochemical testing to not only reduce colorectal cancer incidence but also deaths related to the disease. The latest comes from a study presented of enrollees in two Kaiser Permanente health systems in California for whom completion of FIT within a mailed outreach screening program yielded a mortality benefit across all racial and ethnic groups.
“In this study, completion of one or more FITs in the time prior to the reference date was